# Effect of Lifitegrast 5% on Tear Film Markers

> **NCT03952481** · PHASE4 · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Dry Eye
- Dry Eye Syndromes
- Dry Eyes Chronic

## Interventions

- **DRUG:** Lifitegrast 5% Ophthalmic Solution

## Key facts

- **NCT ID:** NCT03952481
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** COVID restrictions
- **Last updated:** 2021-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03952481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03952481, "Effect of Lifitegrast 5% on Tear Film Markers". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT03952481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*